Q1 EPS Estimates for Aspen Aerogels Raised by Roth Capital

Aspen Aerogels, Inc. (NYSE:ASPN) – Equities researchers at Roth Capital boosted their Q1 2025 earnings per share estimates for Aspen Aerogels in a research report issued on Friday, November 8th. Roth Capital analyst C. Moore now forecasts that the construction company will earn $0.04 per share for the quarter, up from their prior estimate of $0.02. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.10 per share. Roth Capital also issued estimates for Aspen Aerogels’ Q3 2025 earnings at $0.23 EPS.

A number of other analysts have also recently commented on the company. Benchmark restated a “buy” rating and issued a $14.00 price target on shares of Aspen Aerogels in a research report on Thursday, August 8th. Barclays began coverage on Aspen Aerogels in a research note on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price objective for the company. Roth Mkm dropped their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research note on Friday. StockNews.com raised Aspen Aerogels to a “sell” rating in a research note on Thursday, October 31st. Finally, Piper Sandler dropped their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $28.90.

Aspen Aerogels Stock Performance

Shares of ASPN opened at $16.49 on Monday. The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23. The business has a 50-day simple moving average of $23.10 and a two-hundred day simple moving average of $24.67. The stock has a market cap of $1.27 billion, a price-to-earnings ratio of 1,650.65 and a beta of 2.21. Aspen Aerogels has a 52 week low of $8.76 and a 52 week high of $33.15.

Institutional Trading of Aspen Aerogels

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Oppenheimer & Co. Inc. acquired a new stake in Aspen Aerogels during the 1st quarter worth about $388,000. Dakota Wealth Management purchased a new position in shares of Aspen Aerogels during the 3rd quarter valued at about $986,000. Rice Hall James & Associates LLC raised its stake in shares of Aspen Aerogels by 19.9% during the 3rd quarter. Rice Hall James & Associates LLC now owns 535,113 shares of the construction company’s stock valued at $14,817,000 after buying an additional 88,711 shares during the last quarter. Comerica Bank purchased a new position in shares of Aspen Aerogels during the 1st quarter valued at about $1,992,000. Finally, Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of Aspen Aerogels by 66.7% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 80,591 shares of the construction company’s stock valued at $1,922,000 after buying an additional 32,243 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares of the company’s stock, valued at $626,610.60. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at $14,523,709.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.